Tuesday, December 27, 2022
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
Davida F. Kruger, MSN, APN-BC, BC-ADM
Certified Nurse Practitioner
Henry Ford Health System
Division of Endocrinology, Diabetes, Bone
and Mineral Disease
This educational activity is intended for U.S. based PCPs, NPs, and PAs, with emphasis on those who provide care to underserved communities and communities with the greatest needs.
Upon completion of the program, attendees should be able to:
- Explain the rationale for using a weight-centric approach to T2DM management
- Assess guidelines-recommended strategies for using incretin therapies when intensifying treatment in patients with T2DM and overweight/obesity
- Use shared decision making in the selection of treatments for patients with T2DM and overweight/ obesity
ACCREDITATION AND DESIGNATION STATEMENTS
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Credit Designation Statement
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live virtual activity.
Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in the care of patients with management of patients with Type 2 diabetes and obesity.
CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
COMMISION ON DIETETIC REGISTRATION
This program is seeking prior approval with the Commission on Dietetic Registration for dietitians and RDs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at firstname.lastname@example.org
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at email@example.com